Alexander Dahlqvist

Doktorand
Fler filtreringsmöjligheter
  1. 2019
  2. Novel monogalactoside galectin inhibitor scaffolds: Guiding selectivity with heteroaromatic interactions

    Alexander Dahlqvist, 2019 apr 25, 1 uppl. Lund: Lund University, Faculty of Science. 106 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  3. Aminopyrimidine-galactose hybrids are highly selective galectin-3 inhibitors

    Alexander Dahlqvist, Zetterberg, F. R., Hakon Leffler & Ulf J. Nilsson, 2019, I : MedChemComm. 10, 6, s. 913-925 13 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift